-
Mashup Score: 0Pulling Back the Curtain: Robert A. Kyle, MD - ASH Clinical News - 1 year(s) ago
Pulling Back the Curtain: Robert A. Kyle, MD – Pulling Back the Curtain – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1What Is the Best Method for Cytoreduction in Patients With Acute Myeloid Leukemia and Hyperleukocytosis? - ASH Clinical News - 2 year(s) ago
What Is the Best Method for Cytoreduction in Patients With Acute Myeloid Leukemia and Hyperleukocytosis? – Acute Leukemias, Literature Scan, News – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Who’s In and Who’s Out? - ASH Clinical News - 2 year(s) ago
Who’s In and Who’s Out? – Feature Articles, Spotlight – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Who’s In and Who’s Out? - ASH Clinical News - 2 year(s) ago
Who’s In and Who’s Out? – Feature Articles, Spotlight – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Pulling Back the Curtain: Robert A. Kyle, MD - ASH Clinical News - 2 year(s) ago
Pulling Back the Curtain: Robert A. Kyle, MD – Pulling Back the Curtain – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Comparing Apixaban to Warfarin for Reducing Stroke Risk in Thrombotic Antiphospholipid Syndrome - ASH Clinical News - 2 year(s) ago
Comparing Apixaban to Warfarin for Reducing Stroke Risk in Thrombotic Antiphospholipid Syndrome – Blood Advances in a Different Vein, Clotting Disorders, From the Blood Journals, News – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Identifying Nosology of Splenic Marginal Zone B-Cell Lymphoma to Improve Targetable Therapy Development - ASH Clinical News - 2 year(s) ago
Identifying Nosology of Splenic Marginal Zone B-Cell Lymphoma to Improve Targetable Therapy Development – From the Blood Journals, Lymphomas & Lymphoid Neoplasia, News, Written in Blood – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Frontline, Time-Limited Acalabrutinib, Venetoclax, and Obinutuzumab Active in Treatment-Naïve CLL - ASH Clinical News - 2 year(s) ago
Frontline, Time-Limited Acalabrutinib, Venetoclax, and Obinutuzumab Active in Treatment-Naïve CLL – Chronic Leukemias, Literature Scan, News – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Finding a Common Transcriptional Drive Across Bone Marrow Failure Subtypes - ASH Clinical News - 2 year(s) ago
Finding a Common Transcriptional Drive Across Bone Marrow Failure Subtypes – Blood Advances in a Different Vein, From the Blood Journals – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Amgen and Other Drug Makers Drop Discounts for Low-Income Hospitals and Clinics - ASH Clinical News - 2 year(s) ago
Amgen and Other Drug Makers Drop Discounts for Low-Income Hospitals and Clinics – News, Online Exclusives – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
Pulling Back the Curtain: Robert A. Kyle, MD @RobertK68033234 [Oct 1, 2019] @ASHClinicalNews https://t.co/JuR4yazIAD #mmsm https://t.co/QmNSB71LTH